Larry Robbins - 19 May 2026 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: Director
Issuer ticker: CVS
Reported as of: 19 May 2026
Net transaction value: -$352,742,694
SEC form: 4
Accepted by SEC: 21 May 2026, 17:43:42 UTC
Prior SEC filing: 15 May 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Larry M. Robbins

Key filing fact

Larry Robbins filed Form 4 for CVS HEALTH Corp (CVS) on 21 May 2026.

Key facts

This page summarizes Larry Robbins's Form 4 filing for CVS HEALTH Corp (CVS).
8 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2026, 17:43.

Change

Previous filing in this sequence was filed on 15 May 2026.
Current net transaction value: -$352,742,694.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001228603 Primary reporting owner

ROBBINS LARRY

Relationship: Director
Address: 520 MADISON AVENUE, 33RD FLOOR, NEW YORK
Signature: /s/ Larry M. Robbins
Signature date: 21 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Sale

Transaction value: $187,326,935
Shares: -1,983,387
Change %: -24%
Price: $94.45
Shares after: 6,213,412
Date: 19 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F2, F3, F4

CVS transaction

Common Stock

Sale

Transaction value: $14,372
Shares: -151
Change %: -0%
Price: $95.18
Shares after: 6,213,261
Date: 19 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4

CVS transaction

Common Stock

Sale

Transaction value: $74,559,554
Shares: -797,628
Change %: -13%
Price: $93.48
Shares after: 5,415,633
Date: 20 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4, F5

CVS transaction

Common Stock

Sale

Transaction value: $14,476,038
Shares: -152,691
Change %: -2.8%
Price: $94.81
Shares after: 5,262,942
Date: 20 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4, F6

CVS transaction

Common Stock

Sale

Transaction value: $6,398,204
Shares: -66,881
Change %: -1.3%
Price: $95.67
Shares after: 5,196,061
Date: 20 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4, F7

CVS transaction

Common Stock

Sale

Transaction value: $77,026
Shares: -800
Change %: -0.02%
Price: $96.28
Shares after: 5,195,261
Date: 20 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4, F8

CVS transaction

Common Stock

Sale

Transaction value: $34,619,007
Shares: -370,462
Change %: -7.1%
Price: $93.45
Shares after: 4,824,799
Date: 21 May 2026
Ownership: Held by Glenview Investment Funds
Footnotes: F1, F3, F4, F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Cash-Settled Swaps

Sale

Transaction value: $35,271,558
Shares: -378,000
Change %: -100%
Price: $93.31
Shares after: 0
Date: 21 May 2026
Ownership: Held by Glenview Investment Funds
Underlying class: Common Stock
Underlying amount: 378,000
Exercise price: $58.29
Footnotes: F3, F10, F11

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").

Footnote F2

This price reflects the weighted average price for open-market sales of Shares on May 19, 2026 within a $1.00 range. The actual prices for these transactions range from $94.18 to $95.175, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F3

The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

Footnote F4

The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.

Footnote F5

This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $93.25 to $94.19, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F6

This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $94.25 to $95.245, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F7

This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F8

This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $96.25 to $96.34, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F9

This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.

Footnote F10

These cash-settled swaps reference shares of the Issuer's common stock (the "Swaps") and are held for the account of the GO Fund.

Footnote F11

The GO Fund is the record holder of the Swaps. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to the GO Fund. The Reporting Person shares voting and dispositive power over the Swaps held by the GO Fund and may be deemed to beneficially own such Swaps.